PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,409,000 | +3.5% | 3,000,000 | -5.4% | 0.00% | -50.0% |
Q3 2019 | $3,293,000 | -80.5% | 3,170,000 | -79.1% | 0.00% | -75.0% |
Q2 2019 | $16,869,000 | +25.2% | 15,170,000 | +16.7% | 0.01% | +14.3% |
Q1 2019 | $13,479,000 | +574.6% | 13,000,000 | +550.0% | 0.01% | +600.0% |
Q4 2018 | $1,998,000 | -75.2% | 2,000,000 | -71.4% | 0.00% | -75.0% |
Q3 2018 | $8,067,000 | -57.9% | 7,000,000 | -63.7% | 0.00% | -55.6% |
Q2 2018 | $19,172,000 | +22.2% | 19,300,000 | +14.9% | 0.01% | 0.0% |
Q1 2018 | $15,687,000 | +27.8% | 16,800,000 | +6.3% | 0.01% | +28.6% |
Q4 2017 | $12,275,000 | +51.7% | 15,800,000 | +58.0% | 0.01% | +16.7% |
Q3 2017 | $8,089,000 | -40.5% | 10,000,000 | -42.4% | 0.01% | -50.0% |
Q2 2017 | $13,603,000 | -0.1% | 17,350,000 | -17.8% | 0.01% | 0.0% |
Q1 2017 | $13,619,000 | +13.4% | 21,100,000 | +10.5% | 0.01% | 0.0% |
Q4 2016 | $12,009,000 | -19.1% | 19,100,000 | -23.6% | 0.01% | -20.0% |
Q3 2016 | $14,845,000 | – | 25,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PIPER SANDLER & CO. | 3,000,000 | $2,985,000 | 2.72% |
DeepCurrents Investment Group LLC | 31,204,000 | $31,390,000 | 1.25% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 25,417,000 | $25,518,000 | 0.53% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 15,519,000 | $15,732,000 | 0.35% |
WOLVERINE ASSET MANAGEMENT LLC | 19,479,000 | $19,558,000 | 0.20% |
LMR Partners LLP | 9,500,000 | $9,575,000 | 0.16% |
OAKTREE CAPITAL MANAGEMENT LP | 12,663,000 | $12,829,000 | 0.15% |
PURA VIDA INVESTMENTS, LLC | 20,000 | $2,026,000 | 0.12% |
Aequim Alternative Investments LP | 2,000,000 | $2,026,000 | 0.06% |
PALISADE CAPITAL MANAGEMENT, LP | 1,672,000 | $1,681,000 | 0.05% |